CMAB Biopharma Inc., a pure-play, biologics contract manufacturing and development organization (CDMO) and Shenzhen Fapon Biopharma Inc., an innovative biopharmaceutical company, announced a comprehensive strategic agreement for the development and manufacturing of an undisclosed biologic drug project.